Article
Generation of Potent Anti-HER1/2 Immunotoxins by Protein Ligation Using Split Inteins
19 Jun 2018
Abstract excerpt
Cell targeting protein toxins have gained increasing interest for cancer therapy aimed at increasing the therapeutic window and reducing systemic toxicity. Because recombinant expression of immunotoxins consisting of a receptor-binding and a cell-killing moiety is hampered by their high toxicity in a eukaryotic production host, most applications rely on recombinant production of fusion proteins consisting of an...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
